Neutralase heparinase I: Began dose-escalation, Phase I trial in the U.K. to assess safety and pharmacokinetics in 20 healthy volunteers

IBEX Technologies Inc., Montreal Product: Neutralase heparinase I Indication: Reverse heparin action after coronary artery bypass surgery Status: Began dose-escalation, Phase I trial in the U.K. to as...